{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T21:56:53Z","timestamp":1782251813585,"version":"3.54.5"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T00:00:00Z","timestamp":1485993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0171502","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T19:00:03Z","timestamp":1486062003000},"page":"e0171502","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":79,"title":["Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort"],"prefix":"10.1371","volume":"12","author":[{"given":"Eline H.","family":"van den Berg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzyeh","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim C. M. A.","family":"Schreuder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin P. F.","family":"Dullaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas Nico","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrooz Z.","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Blokzijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"R Loomba","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol. Nature Publishing Group"},{"key":"ref2","article-title":"Global Epidemiology of Non-Alcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence and Outcomes","author":"ZM Younossi","year":"2015","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"RJ Wong","year":"2015","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","article-title":"Long-term follow-up of patients with nonalcoholic fatty liver","volume":"7","author":"N Rafiq","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0035-1562943","article-title":"Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease","volume":"35","author":"SK Satapathy","year":"2015","journal-title":"Semin Liver Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"G Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.amjmed.2007.08.041","article-title":"Carotid Artery Intima-media Thickness in Nonalcoholic Fatty Liver Disease","volume":"121","author":"AL Fracanzani","year":"2008","journal-title":"The American Journal of Medicine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep.22845","article-title":"Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population","volume":"49","author":"A Gastaldelli","year":"2009","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"G Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7326\/0003-4819-132-2-200001180-00004","article-title":"Prevalence of and risk factors for hepatic steatosis in Northern Italy","volume":"132","author":"S Bellentani","year":"2000","journal-title":"Ann Intern Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.3748\/wjg.v16.i31.3944","article-title":"Steatosis and steatohepatitis in postmortem material from Northwestern Greece","volume":"16","author":"C-D Zois","year":"2010","journal-title":"World J Gastroenterol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhep.2011.03.020","article-title":"Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort","volume":"56","author":"MJ Armstrong","year":"2012","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/MEG.0b013e32832fcdf0","article-title":"Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain","volume":"22","author":"L Caballer\u00eda","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3945\/ajcn.114.086074","article-title":"Higher fructose intake is inversely associated with risk of nonalcoholic fatty liver disease in older Finnish adults","volume":"100","author":"N Kanerva","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0168-8278(01)00192-1","article-title":"Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects","volume":"35","author":"C Loguercio","year":"2001","journal-title":"J Hepatol"},{"key":"ref16","first-page":"255","article-title":"Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients","volume":"17","author":"C Radu","year":"2008","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/07853890.2014.966752","article-title":"Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study","volume":"47","author":"E Suomela","year":"2015","journal-title":"Ann Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1478-3231.2012.02823.x","article-title":"Heritability of non-alcoholic fatty liver disease and association with abnormal vascular parameters: a twin study","volume":"32","author":"AD Tarnoki","year":"2012","journal-title":"Liver Int"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaad.2013.10.044","article-title":"Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study","volume":"70","author":"EAM van der Voort","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3748\/wjg.v11.i12.1848","article-title":"Hepatic steatosis is associated with an increased risk of carotid atherosclerosis","volume":"11","author":"H V\u00f6lzke","year":"2005","journal-title":"World J Gastroenterol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12902-015-0030-5","article-title":"Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years","volume":"15","author":"U Ludwig","year":"2015","journal-title":"BMC Endocr Disord"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1471-2458-10-237","article-title":"Non-alcoholic and alcoholic fatty liver disease\u2014two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey","volume":"10","author":"A Kotronen","year":"2010","journal-title":"BMC Public Health"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MEG.0b013e328011438b","article-title":"High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity","volume":"19","author":"GV Papatheodoridis","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.20689","article-title":"Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town","volume":"41","author":"GM Pendino","year":"2005","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10654-007-9204-4","article-title":"Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study","volume":"23","author":"RP Stolk","year":"2008","journal-title":"Eur J Epidemiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/ije\/dyu229","article-title":"Cohort Profile: LifeLines, a three-generation cohort study and biobank","volume":"44","author":"S Scholtens","year":"2015","journal-title":"Int J Epidemiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e0137203","DOI":"10.1371\/journal.pone.0137203","article-title":"Representativeness of the LifeLines Cohort Study","volume":"10","author":"B Klijs","year":"2015","journal-title":"PLoS ONE"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"G Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"ref29","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","year":"2016","journal-title":"J Hepatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"SM Grundy","year":"2005","journal-title":"Circulation"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"AS Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","article-title":"Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values","volume":"53","author":"AS Levey","year":"2007","journal-title":"Clin Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"JD Browning","year":"2004","journal-title":"Hepatology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/liv.12226","article-title":"Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)","volume":"33","author":"S Verma","year":"2013","journal-title":"Liver Int"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/ajcn\/87.4.801","article-title":"Consequences of smoking for body weight, body fat distribution, and insulin resistance","volume":"87","author":"A Chiolero","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jhep.2009.03.026","article-title":"Second-hand smoke stimulates lipid accumulation in the liver by modulating AMPK and SREBP-1","volume":"51","author":"H Yuan","year":"2009","journal-title":"J Hepatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/gut.2007.140087","article-title":"Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery","volume":"58","author":"V Trak-Smayra","year":"2009","journal-title":"Gut"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jhep.2011.05.027","article-title":"Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease","volume":"56","author":"C Yu","year":"2012","journal-title":"J Hepatol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2362.2011.02597.x","article-title":"Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome","volume":"42","author":"Y Yilmaz","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/2277-9175.176368","article-title":"Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver","volume":"5","author":"M Foroughi","year":"2016","journal-title":"Adv Biomed Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1210\/en.2003-0285","article-title":"Minireview: adiposity, inflammation, and atherogenesis","volume":"144","author":"CJ Lyon","year":"2003","journal-title":"Endocrinology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.clinbiochem.2015.06.016","article-title":"A pro-inflammatory glycoprotein biomarker is associated with lower bilirubin in metabolic syndrome","volume":"48","author":"RPF Dullaart","year":"2015","journal-title":"Clin Biochem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7861\/clinmedicine.6-1-19","article-title":"Non-alcoholic fatty liver disease: current concepts and management strategies","volume":"6","author":"CP Day","year":"2006","journal-title":"Clin Med (Lond)"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","author":"DC Rockey","year":"2009","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/apt.12963","article-title":"Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease","volume":"40","author":"L Fedchuk","year":"2014","journal-title":"Aliment Pharmacol Ther"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0171502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T06:15:50Z","timestamp":1568787350000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0171502"}},"subtitle":[],"editor":[{"given":"Salvatore","family":"Petta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0171502","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,2]]}}}